Vanderbilt-Ingram Cancer Center

The VICC.ORG Investigator Directory

David L. Page, M.D.

Professor of Pathology and Preventive Medicine
VICC Member
Pathologist

Contact Information:

Vanderbilt University Medical Center
C-3311 Medical Center North
Nashville, TN 37232-2561
615-322-3759

Research Specialty:

Breast Cancer

Publications:

• Dupont, WD, Breyer, JP, Bradley, KM, Schuyler, PA, Plummer, WD, Sanders, ME, Page, DL, Smith, JR Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Cancer, 116(1), 8-19, 2010.
• Hughes, LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen MA, Ingle JN, Recht A,Wood WC "Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group." J Clin Oncol, 27(32), 5319-24, 2009 .
• Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS, Ginsberg M, Wassertheil-Smoller S, Page DL "A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease." Breast Cancer Res Treat, 116(2), 339-50, 2009.
• Breyer, JP, Sanders, ME, Airey, DC, Cai, Q, Yaspan, BL, Schuyler, PA, Dai, Q, Boulos, F, Olivares, MG, Bradley, KM, Gao, YT, Page, DL, Dupont, WD, Zheng, W, Smith, JR Heritable variation of ERBB2 and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 18(4), 1252-8, 2009.
• Cui Y, Page DL, Lane DS, Rohan TE "Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study." Breast Cancer Res Treat, 114(1), 113-20, 2009.
• Williams GM, Caldwell J, Armstrong D, Bartsch H, Bevan R, Browne RW, Chipman JK, Iatropoulos MJ, Jeffrey AM, Lunec J, Nair J, Page DL, Reeves BC, Richardson A, Silverstein B, Williams DF "Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implants." Regul Toxicol Pharmacol, 53(2), 107-20, 2009.
• Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Tan LK, Weaver DL, Winer E "Protocol for the examination of specimens from patients with invasive carcinomaof the breast." Arch Pathol Lab Med, 133(10), 1515-38, 2009.
• Page RN, Dittrich L, King R, Boulos F, Page DL "Syringomatous adenoma of the nipple occurring within a supernumerary breast: a case report." J Cutan Pathol, 36(11), 1206-9, 2009.
• Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL "Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial." J Natl Cancer Inst, 100(8), 563-71, 2008.
• Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, Page DL "Estrogen plus progestin and risk of benign proliferative breast disease." Cancer Epidemiol Biomarkers Prev., 17(9), 2337-43, 2008.
• Boulos, FI, Dupont, WD, Simpson, JF, Schuyler, PA, Sanders, ME, Freudenthal, ME, Page, DL Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer, 113(9), 2415-21, 2008.
• Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, Lane DS, Neuhouser ML, Shikany JM, Wassertheil-Smoller S, Page DL "Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial." Cancer Prev Res, 1(4), 275-84, 2008.
• Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE "Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast." Int J Cancer, 121(6), 1346-51, 2007.
• Cui Y, Page DL, Chlebowski RT, Hsia J, Allan Hubbell F, Johnson KC, Rohan TE "Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative." Cancer Causes Control, 18(4), 431-8, 2007.
• Page, DL Why I became a surgical pathologist with interest in breast disease. J Clin Pathol, 60(3), 251-2, 2007.
• Fong D, Lann MA, Finlayson C, Page DL, Singh M "Diabetic (lymphocytic) mastopathy with exuberant lymphohistiocytic and granulomatous response: a case report with review of the literature." Am J Surg Pathol, 30(10), 1330-6, 2006.
• McLaren, BK, Schuyler, PA, Sanders, ME, Jensen, RA, Simpson, JF, Dupont, WD, Page, DL Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer, 107(6), 1227-33, 2006.
• Chen Z, Abidi BR, Page DL, Abidi MA "Gray-level grouping (GLG): an automatic method for optimized image contrast enhancement-Part I: the basic method." IEEE Trans Image Process, 15(8), 2290-302, 2006.
• Sanders, ME, Page, DL, Simpson, JF, Schuyler, PA, Dale Plummer, W, Dupont, WD Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer, 106(7), 1453-61, 2006.
• Lagios MD, Page DL, Silverstein MJ "Prospective study of wide excision alone for ductal carcinoma in situ of the breast." J Clin Oncol, 24(23), 3809-11, 2006.
• Carter BA, Page DL "Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact." J Clin Oncol, 24(13), 1978-9, 2006.
• Page, DL Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat, 93(3), 189-90, 2005.
• McLaren, BK, Smith, J, Schuyler, PA, Dupont, WD, Page, DL Adenomyoepithelioma: clinical, histologic, and immunohistologic evaluation of a series of related lesions. Am J Surg Pathol, 29(10), 1294-9, 2005.
• Page DL "Apocrine carcinomas of the breast." Breast, 14(1), 1-2, 2005.
• Gobbi H, Dupont WD, Parl FF, Schuyler PA, Plummer WD, Olson SJ, Page DL "Breast cancer risk associated with estrogen receptor exprerssion in epothelial hyperplasia lacking atypia and adjacent lobular units." Int J Cancer, 113(5), 857-9, 2005.
• Edge SB, Sobin LH, Page DL, Gospodarowicz MK, Greene FL, Winchester DP "Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging." J Natl Cancer Inst, 97(6), 463-4, 2005.
• Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, Holmes DR, Hughes LL, Jackman RJ, Julian TB, Kuerer HM, Mabry HC, McCready DR, McMasters KM, Page DL, Parker SH, Pass HA, Pegram M, Rubin E, Stavros AT, Tripathy D, Vicini F, Whitworth PW "Image-detected breast cancer: state of the art diagnosis and treatment." J Am Coll Surg, 201(4), 586-97, 2005.
• McLaren, BK, Gobbi, H, Schuyler, PA, Olson, SJ, Parl, FF, Dupont, WD, Page, DL Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study. Am J Surg Pathol, 29(1), 105-8, 2005.
• Sanders, ME, Schuyler, PA, Dupont, WD, Page, DL The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer, 103(12), 2481-4, 2005.
• Page DL, Simpson JF "What is atypical lobular hyperplasia and what does it mean for the patient?." J Clin Oncol, 23(24), 5432-3, 2005.
• Page, David L Breast lesions, pathology and cancer risk. Breast J, 10 Suppl 1S3-4, 2004.
• Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA "Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America." Mod Pathol, 17(5), 489-95, 2004.
• Carter BA, Page DL "Phyllodes tumor of the breast: local recurrence versus metastatic capacity." Hum Pathol, 35(9), 1051-2, 2004.
• Fajardo LL, Pisano ED, Caudry KJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ; Radiologist Investigators of the Radiologic Diagnostic Oncology Group V "Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study." Acad Radiol, 11(3), 293-308, 2004.
• Page, David L, Schuyler, Peggy A, Dupont, William D, Jensen, Roy A, Plummer, W Dale, Simpson, Jean F, Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.. Lancet, 361125-9, 2003.
• Jensen, Roy A, Page, David L, Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions.. Am J Surg Pathol, 27828-31, 2003.
• Gobbi, Helenice, Simpson, Jean F, Jensen, Roy A, Olson, Sandra J, Page, David L Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol, 16(9), 893-901, 2003.
• Acs, Geza, Simpson, Jean F, Bleiweiss, Ira J, Hugh, Judith, Reynolds, Carol, Olson, Sandy, Page, David L, Microglandular adenosis with transition into adenoid cystic carcinoma of the breast.. Am J Surg Pathol, 271052-60, 2003.
• Page, David L, Special types of invasive breast cancer, with clinical implications.. Am J Surg Pathol, 27832-5, 2003.
• Singletary, S Eva, Allred, Craig, Ashley, Pandora, Bassett, Lawrence W, Berry, Donald, Bland, Kirby I, Borgen, Patrick I, Clark, Gary M, Edge, Stephen B, Hayes, Daniel F, Hughes, Lorie L, Hutter, Robert V P, Morrow, Monica, Page, David L, Recht, Abram, Theriault, Richard L, Thor, Ann, Weaver, Donald L, Wieand, H Samuel, Greene, Frederick L, Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.. Surg Clin North Am, 83803-19, 2003.
• Page, D L Expert commentary. Histopathology, 41(3A), 152-3, 2002.
• Gobbi, H, Jensen, R A, Simpson, J F, Olson, S J, Page, D L Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion. Hum Pathol, 32(8), 785-90, 2001.
• Ely, K A, Carter, B A, Jensen, R A, Simpson, J F, Page, D L Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol, 25(8), 1017-21, 2001.
• Fu, C, Bardhan, S, Cetateanu, N D, Wamil, B D, Wang, Y, Yan, H P, Shi, E, Carter, C, Venkov, C, Yakes, F M, Page, D L, Lloyd, R S, Mernaugh, R L, Hellerqvist, C G Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis. Clin Cancer Res, 7(12), 4182-94, 2001.
• Simpson, J F, Page, D L Pathology of preinvasive and excellent prognosis breast cancer. Curr Opin Oncol, 13(6), 426-30, 2001.
• Page, D L, Gray, R, Allred, D C, Dressler, L G, Hatfield, A K, Martino, S, Robert, N J, Wood, W C Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol, 24(1), 10-8, 2001.
• Carter, B A, Jensen, R A, Simpson, J F, Page, D L Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol, 113(2), 259-65, 2000.
• Ely, K A, Tse, G, Simpson, J F, Clarfeld, R, Page, D L Diabetic mastopathy. A clinicopathologic review. Am J Clin Pathol, 113(4), 541-5, 2000.
• Page, D L, Jensen, R A, Simpson, J F, Dupont, W D Historical and epidemiologic background of human premalignant breast disease. J Mammary Gland Biol Neoplasia, 5(4), 341-9, 2000.
• Gobbi, H, Arteaga, C L, Jensen, R A, Simpson, J F, Dupont, W D, Olson, S J, Schuyler, P A, Plummer, W D, Page, D L Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology, 36(2), 168-77, 2000.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 12(6), 526-31, 2000.
• Simpson, J F, Gray, R, Dressler, L G, Cobau, C D, Falkson, C I, Gilchrist, K W, Pandya, K J, Page, D L, Robert, N J Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol, 18(10), 2059-69, 2000.
• Page, D L, Ruby, S G Protocol for the examination of specimens from patients with malignant adrenal cortical tumors and pheochromocytomas, exclusive of neuroblastoma and other adrenal medullary tumors of childhood: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med, 124(1), 17-20, 2000.
• Gobbi, H, Tse, G, Page, D L, Olson, S J, Jensen, R A, Simpson, J F Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol, 113(2), 288-94, 2000.
• Simpson, J F, Page, D L The p53 tumor suppressor gene in ductal carcinoma in situ of the breast. Am J Pathol, 156(1), 5-6, 2000.
• Goldstein, R E, O'Neill, J A, Holcomb, G W, Morgan, W M, Neblett, W W, Oates, J A, Brown, N, Nadeau, J, Smith, B, Page, D L, Abumrad, N N, Scott, H W Clinical experience over 48 years with pheochromocytoma. Ann Surg, 229(6), 755-64; discussion 764-6, 1999.
• Dupont, W D, Page, D L, Parl, F F, Plummer, W D, Schuyler, P A, Kasami, M, Jensen, R A Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer, 85(6), 1277-83, 1999.
• Gobbi, H, Atkinson, J B, Kardos, T F, Simpson, J F, Page, D L Inflammatory myofibroblastic tumour of the breast: report of a case with giant vacuolated cells. Breast, 8(3), 135-8, 1999.
• Gobbi, H, Simpson, J F, Borowsky, A, Jensen, R A, Page, D L Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer, 85(10), 2170-82, 1999.
• Simpson, J F, Page, D L Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 11(6), 442-6, 1999.
• Gobbi, H, Dupont, W D, Simpson, J F, Plummer, W D, Schuyler, P A, Olson, S J, Arteaga, C L, Page, D L Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst, 91(24), 2096-101, 1999.
• Nørgaard, P, Law, B, Joseph, H, Page, D L, Shyr, Y, Mays, D, Pietenpol, J A, Kohl, N E, Oliff, A, Coffey, R J, Poulsen, H S, Moses, H L Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Clin Cancer Res, 5(1), 35-42, 1999.
• Yan, H P, Carter, C E, Wang, E Z, Page, D L, Washington, K, Wamil, B D, Yakes, F M, Thurman, G B, Hellerqvist, C G Functional studies on the anti-pathoangiogenic properties of CM101. Angiogenesis, 2(3), 219-33, 1998.
• Kasami, M, Olson, S J, Simpson, J F, Page, D L Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study. Histopathology, 32(3), 232-8, 1998.
• Kasami, M, Vnencak-Jones, C L, Manning, S, Dupont, W D, Jensen, R A, Page, D L Monoclonality in fibroadenomas with complex histology and phyllodal features. Breast Cancer Res Treat, 50(2), 185-91, 1998.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent prognosis breast cancer. Curr Opin Oncol, 10(6), 498-503, 1998.
• Page, D L, Jensen, R A, Simpson, J F Premalignant and malignant disease of the breast: the roles of the pathologist. Mod Pathol, 11(2), 120-8, 1998.
• Page, D L, Jensen, R A, Simpson, J F Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat, 51(3), 195-208, 1998.
• Battles, O E, Page, D L, Johnson, J E Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol, 108(1), 6-12, 1997.
• Scott, M A, Lagios, M D, Axelsson, K, Rogers, L W, Anderson, T J, Page, D L Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol, 28(8), 967-73, 1997.
• Kasami, M, Vnencak-Jones, C L, Manning, S, Dupont, W D, Page, D L Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy. Am J Pathol, 150(6), 1925-32, 1997.
• Page, D L, Gray, G F Pathology of mammographically discovered breast cancer. Clinical implications of size and histologic differentiation. Surg Oncol Clin N Am, 6(2), 335-42, 1997.
• Simpson, J F, Page, D L Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 9(6), 512-9, 1997.
• Page, D L, Johnson, J E, Dupont, W D Probabilistic approach to the reporting of fine-needle aspiration cytology of the breast. Cancer, 81(1), 6-9, 1997.
• Page, D L Prognostic indicators in breast cancer and who needs them. Anat Pathol, 235-52, 1997.
• Jensen, R A, Page, D L, Holt, J T RAP-PCR using RNA from tissue microdissection. Methods Mol Biol, 85277-83, 1997.
• Thurman, G B, Page, D L, Wamil, B D, Wilkinson, L E, Kasami, M, Hellerqvist, C G Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin). J Cancer Res Clin Oncol, 122(9), 549-53, 1996.
• Jensen, R A, Thompson, M E, Jetton, T L, Szabo, C I, van der Meer, R, Helou, B, Tronick, S R, Page, D L, King, M C, Holt, J T BRCA1 is secreted and exhibits properties of a granin. Nat Genet, 12(3), 303-8, 1996.
• Fleischer, A C, Cullinan, J A, Jones, H W, Page, D L Correlation of histomorphology of ovarian masses with color Doppler sonography. Ultrasound Med Biol, 22(5), 555-9, 1996.
• Kolquist, K A, Vnencak-Jones, C L, Swift, L, Page, D L, Johnson, J E, Denison, M R Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med, 16(1), 71-82, 1996.
• Page, D L, Dupont, W D, Jensen, R A Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 5(1), 29-32, 1996.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 8(6), 462-7, 1996.
• Page, D L, Salhany, K E, Jensen, R A, Dupont, W D Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer, 78(2), 258-66, 1996.
• Page, D L The woman at high risk for breast cancer. Importance of hyperplasia. Surg Clin North Am, 76(2), 221-30, 1996.
• Page, D L, Steel, C M, Dixon, J M ABC of breast diseases. Carcinoma in situ and patients at high risk of breast cancer. BMJ, 310(6971), 39-42, 1995.
• Page, D L, Dupont, W D, Rogers, L W, Jensen, R A, Schuyler, P A Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer, 76(7), 1197-200, 1995.
• Page, D L, Johnson, J E Controversies in the local management of invasive and non-invasive breast cancer. Cancer Lett, 90(1), 91-6, 1995.
• Thompson, M E, Jensen, R A, Obermiller, P S, Page, D L, Holt, J T Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet, 9(4), 444-50, 1995.
• Pierce, D F, Gorska, A E, Chytil, A, Meise, K S, Page, D L, Coffey, R J, Moses, H L Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A, 92(10), 4254-8, 1995.
• Johnson, J E, Page, D L, Winfield, A C, Reynolds, V H, Sawyers, J L Recurrent mammary carcinoma after local excision. A segmental problem. Cancer, 75(7), 1612-8, 1995.
• O'Malley, F P, Page, D L, Nelson, E H, Dupont, W D Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. Hum Pathol, 25(2), 164-8, 1994.
• Lennington, W J, Jensen, R A, Dalton, L W, Page, D L Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer, 73(1), 118-24, 1994.
• Thurman, G B, Russel, B A, York, G E, Wang, Y F, Page, D L, Sundell, H W, Hellerqvist, C G Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors. J Cancer Res Clin Oncol, 120(8), 479-84, 1994.
• Page, D L, Jensen, R A Evaluation and management of high risk and premalignant lesions of the breast. World J Surg, 18(1), 32-8, 1994.
• Jensen, R A, Page, D L, Holt, J T Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc Natl Acad Sci U S A, 91(20), 9257-61, 1994.
• Dupont, W D, Page, D L, Parl, F F, Vnencak-Jones, C L, Plummer, W D, Rados, M S, Schuyler, P A Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med, 331(1), 10-5, 1994.
• Page, D L, Lagios, M D Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast. Cancer Lett, 86(1), 1-4, 1994.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 6(6), 549-53, 1994.
• O'Malley, F P, Vnencak-Jones, C L, Dupont, W D, Parl, F, Manning, S, Page, D L p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab Invest, 71(1), 67-72, 1994.
• Page, D L, Dupont, W D Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat, 28(2), 157-66, 1993.
• Hellerqvist, C G, Thurman, G B, Page, D L, Wang, Y F, Russell, B A, Montgomery, C A, Sundell, H W Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus. J Cancer Res Clin Oncol, 120(1-2), 63-70, 1993.
• O'Malley, F, Casey, T T, Winfield, A C, Rodgers, W H, Sawyers, J, Page, D L Clinical correlates of false-negative fine needle aspirations of the breast in a consecutive series of 1,005 patients. Surg Gynecol Obstet, 176(4), 360-4, 1993.
• Jensen, R A, Dupont, W D, Page, D L Diagnostic criteria and cancer risk of proliferative breast lesions. J Cell Biochem Suppl, 17G59-64, 1993.
• Holt, J T, Jensen, R A, Page, D L Histopathology: old principles and new methods. Cancer Surv, 18115-33, 1993.
• Lennington, W J, Gray, G F, Page, D L Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe. Am J Dis Child, 147(2), 193-6, 1993.
• Simpson, J F, Page, D L Altered expression of a structural protein (fodrin) within epithelial proliferative disease of the breast. Am J Pathol, 141(2), 285-9, 1992.
• Page, D L, Dupont, W D Benign breast disease: indicators of increased breast cancer risk. Cancer Detect Prev, 16(2), 93-7, 1992.
• Page, D L, Rogers, L W Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol, 23(10), 1095-7, 1992.
• Dutt, P L, Baxter, J W, O'Malley, F P, Glick, A D, Page, D L Distant cutaneous metastasis of pleural malignant mesothelioma. J Cutan Pathol, 19(6), 490-5, 1992.
• Simpson, J F, Dutt, P L, Page, D L Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol, 23(6), 608-11, 1992.
• Page, D L, Dupont, W D Indicators of increased breast cancer risk in humans. J Cell Biochem Suppl, 16G175-82, 1992.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent-prognosis cancers. Curr Opin Oncol, 4(6), 1010-6, 1992.
• Glick, A D, Page, D L Primitive neuroepithelial tumors with vermiform processes (filiform neuroepithelial tumors). Immunocytochemical and ultrastructural study of 2 cases. Pathol Res Pract, 188(6), 687-91, 1992.
• Simpson, J F, Page, D L Prognostic value of histopathology in the breast. Semin Oncol, 19(3), 254-62, 1992.
• Casey, T T, Rodgers, W H, Baxter, J W, Sawyers, J L, Reynolds, V H, Page, D L Stratified diagnostic approach to fine needle aspiration of the breast. Am J Surg, 163(3), 305-11, 1992.
• Arteaga, C L, Johnson, M D, Todderud, G, Coffey, R J, Carpenter, G, Page, D L Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A, 88(23), 10435-9, 1991.
• Page, D L, Kidd, T E, Dupont, W D, Simpson, J F, Rogers, L W Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol, 22(12), 1232-9, 1991.
• Dupont, W D, Page, D L Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med, 151(1), 67-72, 1991.
• Page, D L Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol, 15(4), 334-49, 1991.
• Page, D L, Dupont, W D Proliferative breast disease: diagnosis and implications. Science, 253(5022), 915-6, 1991.
• Page, D L, Dupont, W D Anatomic markers of human premalignancy and risk of breast cancer. Cancer, 66(6 Suppl), 1326-35, 1990.
• Moore, D E, Segars, J H, Winfield, A C, Page, D L, Eisenberg, A D, Holburn, G E Effects of contrast agents on the fallopian tube in a rabbit model. Radiology, 176(3), 721-4, 1990.
• Page, D L, Simpson, J F Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol, 2(6), 1031-7, 1990.
• Page, D L, Dupont, W D Premalignant conditions and markers of elevated risk in the breast and their management. Surg Clin North Am, 70(4), 831-51, 1990.
• Fleischer, A C, McKee, M S, Gordon, A N, Page, D L, Kepple, D M, Worrell, J A, Jones, H W, Burnett, L S, James, A E Transvaginal sonography of postmenopausal ovaries with pathologic correlation. J Ultrasound Med, 9(11), 637-44, 1990.
• Tham, K T, Page, D L AgNOR and Ki-67 in breast lesions. Am J Clin Pathol, 92(4), 518-20, 1989.
• Salhany, K E, Page, D L Fine-needle aspiration of mammary lobular carcinoma in situ and atypical lobular hyperplasia. Am J Clin Pathol, 92(1), 22-6, 1989.
• Dupont, W D, Page, D L, Rogers, L W, Parl, F F Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer, 63(5), 948-57, 1989.
• Jensen, R A, Page, D L, Dupont, W D, Rogers, L W Invasive breast cancer risk in women with sclerosing adenosis. Cancer, 64(10), 1977-83, 1989.
• Page, D L Pathology of preinvasive and early breast cancer. Curr Opin Oncol, 1(2), 277-83, 1989.
• Eisenberg, A D, Winfield, A C, Page, D L, Holburn, G E, Schifter, T, Segars, J H Peritoneal reaction resulting from iodinated contrast material: comparative study. Radiology, 172(1), 149-51, 1989.
• Dupont, W D, Page, D L Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol, 20(8), 723-5, 1989.
• Page, D L Anatomic markers of human mammary premalignancy and incipient breast cancer. Recent Results Cancer Res, 10665-72, 1988.
• Page, D L, Dupont, W D, Rogers, L W Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol, 19(2), 201-7, 1988.
• Page, D L, Dupont, W D Histopathologic risk factors for breast cancer in women with benign breast disease. Semin Surg Oncol, 4(4), 213-7, 1988.
• Tarr, R W, Kerner, T, McCook, B, Page, D L, Nance, E P, Kaye, J J Primary extraosseous osteogenic sarcoma of the mediastinum: clinical, pathologic, and radiologic correlation. South Med J, 81(10), 1317-9, 1988.
• Sherry, M M, Johnson, D H, Page, D L, Greco, F A, Hainsworth, J D Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy. Am J Med, 79(3), 355-64, 1985.
• Page, D L, Vander Zwaag, R, Rogers, L W, Williams, L T, Walker, W E, Hartmann, W H Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst, 61(4), 1055-63, 1978.
• Scott, H W, Oates, J A, Nies, A S, Burko, H, Page, D L, Rhamy, R K Pheochromocytoma: present diagnosis and management. Ann Surg, 183(5), 587-93, 1976.
• Withers, E H, Page, D L, Hollifield, J, Patton, J A, Rosenfeld, L Carcinoma of the thyroid with description of a new scanning technic. Am J Surg, 130(4), 395-8, 1975.
• Franklin, J D, Reynolds, V H, Page, D L Cutaneous melanoma: a twenty-year retrospective study with clinicopathologic correlation. Plast Reconstr Surg, 56(3), 277-85, 1975.